Asthma is a common, chronic condition affecting nearly 2.8 million people in Australia, and its multi-system impact necessitates a comprehensive and up-to-date approach to patient care. This CPD activity will guide you through the latest evidence-based practices, focusing on the strategic use of triple therapy within a broader management framework.
Healthscope and its Respiratory Physicians have launched a new 4-hour CPD activity, “The Role of Triple Therapy in Respiratory Disease: Asthma”, to revisit your understanding of modern asthma management. This CPD activity is accredited for both Specialists and GPs.
Learning Outcomes:
- Review the incidence and prevalence of Asthma in the Australian community
- Review the multi-system impact of Asthma on patients with the condition
- Outline current treatment and management regimes for patients with Asthma
This is a RACGP CPD module with an allocated 1 hour of Education Activities (EA), 2 hour of Measuring Outcomes (MO), and 1 hour of Reflective Practice (RP) under the RACGP 2023-25 CPD program.
This activity was recorded in September 2025.
